299
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Choline deprivation: An overview of the major hepatic metabolic response pathways

, , , &
Pages 874-886 | Received 03 Mar 2012, Accepted 09 Apr 2012, Published online: 10 May 2012

References

  • Newberne PM. Choline deficiency associated with diethanolamine carcinogenicity. Toxicol Sci 2002;67:1–3.
  • Blusztajn JK. Choline, a vital amine. Science 1998;281:794–5.
  • Best CH, Huntsman ME. The effects of the components of lecithine upon deposition of fat in the liver. J Physiol 1932;75:405–12.
  • Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994;14:269–96.
  • Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006;26:229–50.
  • Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutr Rev 1994;52:327–39.
  • Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1981;1:95–121.
  • Zeisel SH. Choline: an essential nutrient for humans. Nutrition 2000;16:669–71.
  • Liapi C, Feskou I, Zarros A, Galanopoulou P, Tsakiris S. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats. Clin Chem Lab Med 2007;45:651–6.
  • Zeisel SH. Choline deficiency. J Nutr Biochem 1990;1:332–49.
  • da Costa KA, Gaffney CE, Fischer LM, Zeisel SH. Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr 2005;81:440–4.
  • Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci USA 2005;102:16025–30.
  • Konstandi M, Segos D, Galanopoulou P, Theocharis S, Zarros A, Lang MA, Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response. J Appl Toxicol 2009;29:101–9.
  • Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004;229:988–95.
  • Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 2001;276:41611–19.
  • Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996;16:1375–80.
  • Koepsell H, Schmitt BM, Gorboulev V. Organic cation transporters. Rev Physiol Biochem Pharmacol 2003;150:36–90.
  • Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004;447:666–76.
  • Apparsundaram S, Ferguson SM, Blakely RD. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem Soc Trans 2001;29:711–16.
  • Gründemann D, Liebich G, Kiefer N, Köster S, Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 1999;56:1–10.
  • Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 2002;62:1966–70.
  • Institute of Medicine and National Academy of Sciences of the USA. Dietary reference intakes for folate, thiamin, riboflavin, niacin, vitamin B12, panthothenic acid, biotin, and choline. Vol. 1 Washington DC: National Academic Press; 1998. pp 390–422.
  • da Costa KA, Kozyreva OG, Song J, Galanko JA, Fischer LM, Zeisel SH. Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J 2006;20:1336–44.
  • Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003;133:1302–7.
  • Vance DE, Vance JE. editors. Biochemistry of lipids, lipoproteins and membranes. New York: Elsevier; 2008.
  • Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 2005;43:1069–75.
  • Cui Z, Vance JE, Chen MH, Voelker DR, Vance DE. Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a unique membrane fraction in rat liver. J Biol Chem 1993;268:16655–63.
  • Vance DE, Ridgway ND. The methylation of phosphatidylethanolamine. Prog Lipid Res 1988;27:61–79.
  • Reo NV, Adinehzadeh M, Foy BD. Kinetic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis using 13C NMR spectroscopy. Biochim Biophys Acta 2002;1580:171–88.
  • Aoyama C, Liao H, Ishidate K. Structure and function of choline kinase isoforms in mammalian cells. Prog Lipid Res 2004;43:266–81.
  • Vance DE. Phospholipid biosynthesis in eukaryotes. In Vance DE, Vance JE, editors. Biochemistry of lipids, lipoproteins and membranes. Amsterdam: Elsevier; 2002. pp 205–32.
  • Vance DE, Choy PC. How is phosphatidylcholine biosynthesis regulated? Trends Biochem Sci 1979;4:145–8.
  • Fisher MC, Zeisel SH, Mar MH, Sadler TW. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology 2001;64:114–22.
  • Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988;263:2998–3004.
  • Kulinski A, Vance DE, Vance JE. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J Biol Chem 2004;279:23916–24.
  • Yao ZM, Vance DE. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J Biol Chem 1989;264:11373–80.
  • Yao ZM, Vance DE. Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol 1990;68:552–8.
  • Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J Biol Chem 2004;279:47402–10.
  • Noga AA, Zhao Y, Vance DE. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J Biol Chem 2002;277:42358–65.
  • Borgstrom B. Phospholipid absorption. In Rommel H, Bohmer R, editors. Lipid absorption: biochemical and clinical aspects. London: MTP Press Ltd; 1976. pp 65–72.
  • Robins SJ. Recirculation and reutilization of micellar bile lecithin. Am J Physiol 1975;229:598–602.
  • Schneider WJ, Vance DE. Effect of choline deficiency on the enzymes that synthesize phosphatidylcholine and phosphatidylethanolamine in rat liver. Eur J Biochem 1978;85:181–7.
  • Cui Z, Vance DE. Expression of phosphatidylethanolamine N-methyltransferase-2 is markedly enhanced in long term choline-deficient rats. J Biol Chem 1996;271:2839–43.
  • Fischer LM, Scearce JA, Mar MH, Patel JR, Blanchard RT, Macintosh BA, Ad libitum choline intake in healthy individuals meets or exceeds the proposed adequate intake level. J Nutr 2005;135:826–9.
  • Zeisel SH. Choline, homocysteine, and pregnancy. Am J Clin Nutr 2005;82:719–20.
  • Chandar N, Lombardi B. Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet. Carcinogenesis 1988;9:259–63.
  • Rogers AE, Nields HM, Newberne PM. Nutritional and dietary influences on liver tumorigenesis in mice and rats. Arch Toxicol Suppl 1987;10:231–43.
  • Ghoshal AK, Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 1984;5:1367–70.
  • Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995;22:1399–403.
  • Zeisel SH, Da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Choline, an essential nutrient for humans. FASEB J 1991;5:2093–8.
  • Zeisel SH, Mar MH, Zhou Z, da Costa KA. Pregnancy and lactation are associated with diminished concentrations of choline and its metabolites in rat liver. J Nutr 1995;125:3049–54.
  • Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27–41.
  • Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:619–38.
  • Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842–5.
  • Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006;103:12511–16.
  • Adibhatla RM, Hatcher JF. Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res 2005;30:15–23.
  • Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005;CD000269.
  • Adibhatla RM, Hatcher JF, Larsen EC, Chen X, Sun D, Tsao FH. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke. J Biol Chem 2006;281:6718–25.
  • Walkey CJ, Yu L, Agellon LB, Vance DE. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 1998;273:27043–6.
  • Kharbanda KK, Mailliard ME, Baldwin CR, Beckenhauer HC, Sorrell MF, Tuma DJ. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol 2007;46:314–21.
  • Vance DE, Walkey CJ, Cui Z. Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta 1997;1348:142–50.
  • Fischer LM, daCosta KA, Kwock L, Stewart PW, Lu TS, Stabler SP, Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 2007;85:1275–85.
  • Zeisel SH. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline. IUBMB Life 2007;59:380–7.
  • Li Z, Agellon LB, Vance DE. Phosphatidylcholine homeostasis and liver failure. J Biol Chem 2005;280:37798–802.
  • Li Z, Agellon LB, Vance DE. Choline redistribution during adaptation to choline deprivation. J Biol Chem 2007;282:10283–9.
  • Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997;26:670–8.
  • George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003;39:756–64.
  • Yao ZM, Jamil H, Vance DE. Choline deficiency causes translocation of CTP:phosphocholine cytidylyltransferase from cytosol to endoplasmic reticulum in rat liver. J Biol Chem 1990;265:4326–31.
  • Raubenheimer PJ, Nyirenda MJ, Walker BR. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes 2006;55:2015–20.
  • Ghoshal AK, Farber E. Liver biochemical pathology of choline deficiency and of methyl group deficiency: a new orientation and assessment. Histol Histopathol 1995;10:457–62.
  • Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610–14.
  • Angulo P. Treatment of nonalcoholic fatty liver disease. Ann Hepatol 2002;1:12–19.
  • Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004;40:47–51.
  • Besterman JM, Duronio V, Cuatrecasas P. Rapid formation of diacylglycerol from phosphatidylcholine: a pathway for generation of a second messenger. Proc Natl Acad Sci USA 1986;83:6785–9.
  • Ericsson J, Jackson SM, Kim JB, Spiegelman BM, Edwards PA. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J Biol Chem 1997;272:7298–305.
  • Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 1998;273:35299–306.
  • Lagace TA, Storey MK, Ridgway ND. Regulation of phosphatidylcholine metabolism in Chinese hamster ovary cells by the sterol regulatory element-binding protein (SREBP)/SREBP cleavage-activating protein pathway. J Biol Chem 2000;275:14367–74.
  • Kast HR, Nguyen CM, Anisfeld AM, Ericsson J, Edwards PA. CTP:phosphocholine cytidylyltransferase, a new sterol- and SREBP-responsive gene. J Lipid Res 2001;42:1266–72.
  • Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077–82.
  • Hartroft WS. The sequence of pathologic events in the development of experimental fatty liver and cirrhosis. Ann NY Acad Sci 1954;57:633–45.
  • Ghoshal AK, Farber E. Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest 1993;68:255–60.
  • Banni S, Corongiu FP, Dessi MA, Iannone A, Lombardi B, Tomasi A, Free radicals and lipid peroxidation in liver of rats kept on a diet devoid of choline. Free Radic Res Commun 1989;7:233–40.
  • da Costa KA, Niculescu MD, Craciunescu CN, Fischer LM, Zeisel SH. Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. Am J Clin Nutr 2006;84:88–94.
  • Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996;111:1645–53.
  • Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 2002;6:399–406.
  • Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. J Clin Invest 2000;105:1067–75.
  • Albright CD, Liu R, Bethea TC, Da Costa KA, Salganik RI, Zeisel SH. Choline deficiency induces apoptosis in SV40-immortalized CWSV-1 rat hepatocytes in culture. FASEB J 1996;10:510–16.
  • Albright CD, da Costa KA, Craciunescu CN, Klem E, Mar MH, Zeisel SH. Regulation of choline deficiency apoptosis by epidermal growth factor in CWSV-1 rat hepatocytes. Cell Physiol Biochem 2005;15:59–68.
  • Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996;24:200–8.
  • McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34:255–62.
  • James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998;29:495–501.
  • Guengerich FP. Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. Mol Pharmacol 1977;13:911–23.
  • Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal beta-oxidation. Biochim Biophys Acta 1991;1085:141–58.
  • Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166–76.
  • Ekström G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989;38:1313–19.
  • Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993;10:447–52.
  • Takahashi T, Lasker JM, Rosman AS, Lieber CS. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993;17:236–45.
  • Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128–33.
  • Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001;34:13–18.
  • Vendemiale G, Grattagliano I, Caraceni P, Caraccio G, Domenicali M, Dall'Agata M, Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 2001;33:808–15.
  • Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002;282:G193–9.
  • Hasumura Y, Teschke R, Lieber CS. Increased carbon tetrachloride hepatotoxicity, and its mechanism, after chronic ethanol consumption. Gastroenterology 1974;66:415–22.
  • Veteläinen R, van Vliet A, van Gulik TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol 2007;22:1526–33.
  • Repetto MG, Ossani G, Monserrat AJ, Boveris A. Oxidative damage: the biochemical mechanism of cellular injury and necrosis in choline deficiency. Exp Mol Pathol 2010;88:143–9.
  • Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol 2003;38:S38–53.
  • Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004;36:231–42.
  • Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004;39:273–8.
  • Ramadori G, Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology 2004;127:997–1000.
  • Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003;28:105–12.
  • Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl 1996;54:S39–45.
  • Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997;430:195–207.
  • Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006;364:33–60.
  • Alcolado R, Arthur MJ, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci (Lond) 1997;92:103–12.
  • Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Caligiuri A, Cannito S, Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 2006;55:90–7.
  • Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323–30.
  • Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003;38:1188–98.
  • Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175–86.
  • Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037–48.
  • Bachem MG, Melchior R, Gressner AM. The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells. J Clin Chem Clin Biochem 1989;27:555–65.
  • Zeisel SH. Choline. A nutrient that is involved in the regulation of cell proliferation, cell death and cell transformation. In Heber D, Kritchevsky D, editors. Dietary fats, lipids, hormones, and tumorigenesis: new horizons in basic research. New York: Plenum Press; 1996. pp 131–41.
  • Fullerton FR, Hoover K, Mikol YB, Creasia DA, Poirier LA. The inhibition by methionine and choline of liver carcinoma formation in male C3H mice dosed with diethylnitrosamine and fed phenobarbital. Carcinogenesis 1990;11:1301–5.
  • Newberne PM, Suphiphat V, Locniskar M, de Camargo JL. Inhibition of hepatocarcinogenesis in mice by dietary methyl donors methionine and choline. Nutr Cancer 1990;14:175–81.
  • Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994;14:269–96.
  • Rogers AE. Methyl donors in the diet and responses to chemical carcinogens. Am J Clin Nutr 1995;61:659S–65S.
  • Kovacheva VP, Davison JM, Mellott TJ, Rogers AE, Yang S, O'Brien MJ, Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J 2009;23:1054–63.
  • Locker J, Reddy TV, Lombardi B. DNA methylation and hepatocarcinogenesis in rats fed a choline-devoid diet. Carcinogenesis 1986;7:1309–12.
  • Chandar N, Amenta J, Kandala JC, Lombardi B. Liver cell turnover in rats fed a choline-devoid diet. Carcinogenesis 1987;8:669–73.
  • Ghoshal AK, Ahluwalia M, Farber E. The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet. Am J Pathol 1983;113:309–14.
  • Shinozuka H, Lombardi B. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci of gamma-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats. Cancer Res 1980;40:3846–9.
  • Rushmore TH, Lim YP, Farber E, Ghoshal AK. Rapid lipid peroxidation in the nuclear fraction of rat liver induced by a diet deficient in choline and methionine. Cancer Lett 1984;24:251–5.
  • Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI, da Costa KA. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 1997;18:731–8.
  • Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic Biol Med 2005;39:641–50.
  • Holmes-McNary MQ, Baldwin AS Jr, Zeisel SH. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB. J Biol Chem 2001;276:41197–204.
  • Niculescu MD, Craciunescu CN, Zeisel SH. Gene expression profiling of choline-deprived neural precursor cells isolated from mouse brain. Brain Res Mol Brain Res 2005;134:309–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.